In this latest FDA report, the agency indicates it had received 201 reports of suicide or suicidal ideations linked to a wide range of GLP-1 drugs by the end of September 2023, including Ozempic, Wegovy, and Mounjaro, as well as Byetta Bydureon, Saxenda, Trulicity, Victoza and Zepbound
Retatrutide requires careful dose titration
Coverage conditions : Among the firms that do cover these drugs for weight loss: 24% require employees to meet with a professional (e.g., dietitian, psychologist, therapist) before approval
It enhances your desire and is helpful in bonding with your partner
To lower CV risk in type 2 diabetes and CKD, the standards recommend an SGLT2 inhibitor, a nonsteroidal mineralocorticoid receptor antagonist such as finerenone or a GLP-1 receptor agonist